News Release

Ayman El-Hattab, M.D., is awarded the 2010 Genzyme/ACMG Foundation Genetics Fellowship

Ayman W. El-Hattab, M.D., was honored as the 2010-2011 recipient of the Genzyme/American College of Medical Genetics Foundation Clinical Genetics Fellowship in Biochemical Genetics at the ACMG 2010 Annual Clinical Genetics Meeting in Albuquerque, N.M.

Grant and Award Announcement

American College of Medical Genetics and Genomics

Ayman W. El-Hattab, MD, a Medical Genetics fellow at Baylor College of Medicine in Houston, Texas, was honored as the 2010-2011 recipient of the Genzyme/American College of Medical Genetics Foundation (ACMGF) Clinical Genetics Fellowship in Biochemical Genetics at the ACMG 2010 Annual Clinical Genetics Meeting in Albuquerque, NM.

The objective of the Genzyme/ACMGF Award is to support a national fellowship program to encourage the recruitment and training of clinicians in the field of clinical biochemical genetics and especially in the diagnosis, management and treatment of individuals with metabolic diseases. This award grants $75,000 per year to a recipient selected by the ACMG Foundation through a competitive process and will provide for the sponsorship of a trainee's first year of fellowship following residency in a genetics fellowship on biochemical genetic diseases. Dr. El-Hattab will join the Medical Biochemical Genetics fellowship program at Baylor College of Medicine in 2010-2011. In addition, this award will support a clinical study that Dr. El-Hattab will conduct to assess glucose kinetics in patients with MELAS syndrome via stable isotope technology

"The Genzyme/ACMGF Clinical Genetics Fellowship in Biochemical Genetics is essential in the effort to educate new geneticists, as well as advance research and standards of practice in medical genetics in the United States in order to improve health and save lives," said R. Rodney Howell, MD, FACMG, president of the ACMGF.

###

Genzyme Corporation is a generous supporter of the American College of Medical Genetics Foundation and a member in good standing of its Partners in Science program. For more information about the Partners in Science program, go to: www.acmgfoundation.org.

About the American College of Medical Genetics

Founded in 1991, the American College of Medical Genetics (www.acmg.net) advances the practice of medical genetics by providing education, resources and a voice for more than 1400 biochemical, clinical, cytogenetic, medical and molecular geneticists, genetic counselors and other healthcare professionals committed to the practice of medical genetics. ACMG's activities include the development of laboratory and practice standards and guidelines, advocating for quality genetic services in healthcare and in public health, and promoting the development of methods to diagnose, treat and prevent genetic disease. Genetics in Medicine, published monthly, is the official ACMG peer-reviewed journal. ACMG's website (www.acmg.net) offers a variety of resources including Policy Statements, Practice Guidelines variety of resources including Policy Statements, Practice Guidelines, Educational Resources, and a Medical Geneticist Locator. The educational and public health programs of the American College of Medical Genetics are dependent upon charitable gifts from corporations, foundations, and individuals. The American College of Medical Genetics Foundation (www.acmgfoundation.org) is a 501(c)(3) not-for-profit organization dedicated to funding the College's diverse efforts to translate genes into health.

About Genzyme

With many products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and diagnostic testing. For more information, visit www.genzyme.com.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.